According to the recent report “Plasma
Therapy Market by Type (Pure PRP, Leukocyte-Rich
PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous,
Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End
User, Region – Global Forecast to 2021″. The global plasma therapy market is expected to grow from USD
135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0%.
Browse in-depth TOC on “Plasma Therapy Market”
141 – Tables
98 – Figures
210 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333
Factors driving the growth of the plasma
therapy market include rising incidences of trauma and increasing healthcare
expenditure worldwide.
The pure PRP segment is estimated to account for the largest share of the
global plasma therapy market in 2016. This segment is projected to grow at the
highest CAGR from 2016 to 2021. The high growth of the pure PRP segment can be
attributed to its high success rate and its antimicrobial effects.
The autologous segment is estimated to account for the largest share of the
global plasma therapy market in 2016, owing to its safety and effective
results. Prevalence of orthopedic disorders such as arthritis and tendinitis
has propelled the demand for advanced treatment options. This has further
contributed to the growth of the plasma therapy market.
The orthopedic segment is further categorized into arthritis, chronic tendinitis,
and bone repair & regeneration. Similarly, the dermatology segment is
classified into androgenic alopecia and plastic surgery. Among all
applications, the dermatology segment is expected to grow at a high CAGR from
2016 to 2021, owing to increase in the adoption of cosmetic procedures and
prevalence of dermatological disorders such as androgenic alopecia.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186196333
Geographical Analysis and Key Market Players:
Geographically, the market is led by North America, followed by
Europe, Asia-Pacific, and rest of the world (RoW). Growth in the global market
is primarily driven by the increase in aging population and rise in the number
of orthopedic disorders.
Major players in the plasma therapy market include BioLife Plasma Services
(U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia),
Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio
Products Laboratory Ltd. (U.K.), China Biologic Products, Inc. (China), and
Octapharma (Switzerland).
